BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28005261)

  • 1. Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines.
    Capellades J; Teixidor P; Villalba G; Hostalot C; Plans G; Armengol R; Medrano S; Estival A; Luque R; Gonzalez S; Gil-Gil M; Villa S; Sepulveda J; García-Mosquera JJ; Balana C
    Clin Transl Oncol; 2017 Jun; 19(6):727-734. PubMed ID: 28005261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.
    Capellades J; Puig J; Domenech S; Pujol T; Oleaga L; Camins A; Majós C; Diaz R; de Quintana C; Teixidor P; Conesa G; Plans G; Gonzalez J; García-Balañà N; Velarde JM; Balaña C
    J Neurooncol; 2018 Apr; 137(2):367-377. PubMed ID: 29285591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of surgical decision making and resulting outcome in patients with highly eloquent glioblastoma: Results of a multicenter assessment.
    Coburger J; Renovanz M; Ganslandt O; Ringel F; Wirtz CR; von Riehm JS
    Clin Neurol Neurosurg; 2017 Nov; 162():29-35. PubMed ID: 28915414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of the neurosurgeons estimation of extent of resection in glioblastoma.
    Sezer S; van Amerongen MJ; Delye HHK; Ter Laan M
    Acta Neurochir (Wien); 2020 Feb; 162(2):373-378. PubMed ID: 31656985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions.
    Müller DMJ; Robe PA; Ardon H; Barkhof F; Bello L; Berger MS; Bouwknegt W; Van den Brink WA; Conti Nibali M; Eijgelaar RS; Furtner J; Han SJ; Hervey-Jumper SL; Idema AJS; Kiesel B; Kloet A; Mandonnet E; De Munck JC; Rossi M; Sciortino T; Vandertop WP; Visser M; Wagemakers M; Widhalm G; Witte MG; Zwinderman AH; De Witt Hamer PC
    J Neurosurg; 2022 Jan; 136(1):45-55. PubMed ID: 34243150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
    Orringer D; Lau D; Khatri S; Zamora-Berridi GJ; Zhang K; Wu C; Chaudhary N; Sagher O
    J Neurosurg; 2012 Nov; 117(5):851-9. PubMed ID: 22978537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
    J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
    Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
    World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note.
    Shinoda J; Yano H; Yoshimura S; Okumura A; Kaku Y; Iwama T; Sakai N
    J Neurosurg; 2003 Sep; 99(3):597-603. PubMed ID: 12959452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
    Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
    World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early repeat resection for residual glioblastoma: decision-making among an international cohort of neurosurgeons.
    Kim AA; Dono A; Khalafallah AM; Nettel-Rueda B; Samandouras G; Hadjipanayis CG; Mukherjee D; Esquenazi Y
    J Neurosurg; 2022 Dec; 137(6):1618-1627. PubMed ID: 35364590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.
    Sonabend AM; Zacharia BE; Cloney MB; Sonabend A; Showers C; Ebiana V; Nazarian M; Swanson KR; Baldock A; Brem H; Bruce JN; Butler W; Cahill DP; Carter B; Orringer DA; Roberts DW; Sagher O; Sanai N; Schwartz TH; Silbergeld DL; Sisti MB; Thompson RC; Waziri AE; Ghogawala Z; McKhann G
    Neurosurgery; 2017 Apr; 80(4):590-601. PubMed ID: 27509070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
    Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
    Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis.
    Noorbakhsh A; Tang JA; Marcus LP; McCutcheon B; Gonda DD; Schallhorn CS; Talamini MA; Chang DC; Carter BS; Chen CC
    J Neurosurg; 2014 Jan; 120(1):31-9. PubMed ID: 24205904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945.
    Wisoff JH; Boyett JM; Berger MS; Brant C; Li H; Yates AJ; McGuire-Cullen P; Turski PA; Sutton LN; Allen JC; Packer RJ; Finlay JL
    J Neurosurg; 1998 Jul; 89(1):52-9. PubMed ID: 9647172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudoprogression in glioblastoma patients: the impact of extent of resection.
    Park HH; Roh TH; Kang SG; Kim EH; Hong CK; Kim SH; Ahn SS; Lee SK; Choi HJ; Cho J; Kim SH; Lee KS; Suh CO; Chang JH
    J Neurooncol; 2016 Feb; 126(3):559-66. PubMed ID: 26608521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.
    Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC
    World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.
    Schucht P; Knittel S; Slotboom J; Seidel K; Murek M; Jilch A; Raabe A; Beck J
    Acta Neurochir (Wien); 2014 Feb; 156(2):305-12; discussion 312. PubMed ID: 24449075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.
    Schucht P; Beck J; Abu-Isa J; Andereggen L; Murek M; Seidel K; Stieglitz L; Raabe A
    Neurosurgery; 2012 Nov; 71(5):927-35; discussion 935-6. PubMed ID: 22895402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.